To our knowledge, this is the first study to provide evidence that genetic variants in CFH and CFHR1/R3 are associated with blood pressure, in accordance with previous observations that increased plasma C3 levels may contribute to hypertension risk [3], [19], [23]–[26]. Here, C3 is linked to hypertensive disorder.